Drug Type AAV based gene therapy |
Synonyms Adeno-Associated Virus Serotype 8 carrying the Membrane Frizzled Related Protein (MFRP) transgene |
Target |
Action modulators |
Mechanism MFRP modulators(membrane frizzled-related protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Retinal Dystrophies | Preclinical | United States | 10 Jun 2025 |





